Jang, Ho-Young <br/><br/>
Optimized Gemcitabine Therapy in Combination with E7 Peptide Immunization Elicits Tumor Cure by Preventing Ag-Specific CTL Inhibition in Animals with Large Established Tumors.  [electronic resource] 

 -  DNA and cell biology  Oct 2018 
 - 850-860 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1557-7430 
<br/><br/><label>Standard No.: </label>10.1089/dna.2018.4319  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--genetics<br/>Animals<br/>Antibodies--pharmacology<br/>Antigens, Neoplasm--administration & dosage<br/>Antimetabolites, Antineoplastic--pharmacology<br/>Cancer Vaccines--administration & dosage<br/>Cell Line, Tumor<br/>Combined Modality Therapy--methods<br/>Cytotoxicity, Immunologic--drug effects<br/>Deoxycytidine--analogs & derivatives<br/>Drug Therapy--methods<br/>Epithelial Cells--drug effects<br/>Female<br/>Humans<br/>Immunization<br/>Immunotherapy--methods<br/>Mice<br/>Mice, Inbred C57BL<br/>Neoplasm Transplantation<br/>Oligodeoxyribonucleotides--administration & dosage<br/>Peptides--administration & dosage<br/>T-Lymphocytes, Cytotoxic--drug effects<br/>Tumor Burden--drug effects<br/>Tumor Necrosis Factor Receptor Superfamily, Member 9--antagonists & inhibitors<br/>Gemcitabine